logo

For the Inventor, By the Inventor

Tokyo, Japan

Takeshi Iwatsubo

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Eisai R&d Management Co., Ltd., Other. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Iwatsubo. Retrieved from https://idiyas.com/inventor/takeshi-iwatsubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bunkyo-ku, Tokyo, JP (2009)
  • Tokyo, JP (2011 - 2012)

Company Filing History:

goldMedal3 out of 530 
 
Eisai R&d Management Co., Ltd.
 patents
silverMedal2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 8173775 - Collagen-like protein CLAC, a precursor thereof, and genes encoding the same (2012-05-08),
2. 7888076 - Collagen-like protein CLAC, precursor thereof and genes encoding the same (2011-02-15),
3. 7514542 - Collagen-like protein CLAC, precursor thereof and genes encoding the same (2009-04-07),

Title: The Innovations of Takeshi Iwatsubo

Introduction

Takeshi Iwatsubo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the study of proteins related to Alzheimer's disease. With a total of 3 patents, his work has garnered attention for its potential impact on diagnosing and treating neurodegenerative conditions.

Latest Patents

Iwatsubo's latest patents include groundbreaking research on a novel human collagen-like protein known as CLAC. This protein occurs in brain amyloid and has a precursor called CLAC-P. His patents detail the genes encoding these proteins, the cDNA of mouse CLAC-P, and its deduced amino acid sequence. Additionally, he has developed antibodies specific to these proteins and methods for diagnosing, treating, and preventing Alzheimer's disease using this innovative approach.

Career Highlights

Throughout his career, Takeshi Iwatsubo has worked with Eisai R&D Management Co., Ltd., where he has contributed to various research initiatives. His expertise in protein research has positioned him as a key figure in the fight against Alzheimer's disease.

Collaborations

Iwatsubo has collaborated with notable colleagues in his field, including Tadafumi Hashimoto and Yasuo Nagai. These partnerships have further advanced the research and development of therapeutic strategies for neurodegenerative diseases.

Conclusion

Takeshi Iwatsubo's innovative work in the field of protein research has the potential to revolutionize the understanding and treatment of Alzheimer's disease. His contributions are invaluable to the scientific community and hold promise for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…